Revvity Retained Earnings (Accumulated Deficit) 2010-2024 | RVTY
Revvity retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Revvity retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $5.759B, a 3.97% increase year-over-year.
- Revvity retained earnings (accumulated deficit) for 2023 were $5.609B, a 13.29% increase from 2022.
- Revvity retained earnings (accumulated deficit) for 2022 were $4.951B, a 12.09% increase from 2021.
- Revvity retained earnings (accumulated deficit) for 2021 were $4.417B, a 25.94% increase from 2020.
| Revvity Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $5,609 |
| 2022 | $4,951 |
| 2021 | $4,417 |
| 2020 | $3,507 |
| 2019 | $2,812 |
| 2018 | $2,602 |
| 2017 | $2,381 |
| 2016 | $2,119 |
| 2015 | $1,991 |
| 2014 | $1,811 |
| 2013 | $1,684 |
| 2012 | $1,549 |
| 2011 | $1,511 |
| 2010 | $1,535 |
| 2009 | $1,289 |
| Revvity Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $5,759 |
| 2024-06-30 | $5,673 |
| 2024-03-31 | $5,627 |
| 2023-12-31 | $5,609 |
| 2023-09-30 | $5,539 |
| 2023-06-30 | $5,539 |
| 2023-03-31 | $5,512 |
| 2022-12-31 | $4,951 |
| 2022-09-30 | $4,834 |
| 2022-06-30 | $4,757 |
| 2022-03-31 | $4,585 |
| 2021-12-31 | $4,417 |
| 2021-09-30 | $4,236 |
| 2021-06-30 | $4,117 |
| 2021-03-31 | $3,879 |
| 2020-12-31 | $3,507 |
| 2020-09-30 | $3,135 |
| 2020-06-30 | $2,966 |
| 2020-03-31 | $2,837 |
| 2019-12-31 | $2,812 |
| 2019-09-30 | $2,755 |
| 2019-06-30 | $2,704 |
| 2019-03-31 | $2,643 |
| 2018-12-31 | $2,602 |
| 2018-09-30 | $2,532 |
| 2018-06-30 | $2,463 |
| 2018-03-31 | $2,407 |
| 2017-12-31 | $2,381 |
| 2017-09-30 | $2,429 |
| 2017-06-30 | $2,346 |
| 2017-03-31 | $2,150 |
| 2016-12-31 | $2,119 |
| 2016-09-30 | $2,061 |
| 2016-06-30 | $2,011 |
| 2016-03-31 | $1,955 |
| 2015-12-31 | $1,991 |
| 2015-09-30 | $1,931 |
| 2015-06-30 | $1,884 |
| 2015-03-31 | $1,843 |
| 2014-12-31 | $1,811 |
| 2014-09-30 | $1,788 |
| 2014-06-30 | $1,753 |
| 2014-03-31 | $1,711 |
| 2013-12-31 | $1,684 |
| 2013-09-30 | $1,625 |
| 2013-06-30 | $1,593 |
| 2013-03-31 | $1,573 |
| 2012-12-31 | $1,549 |
| 2012-09-30 | $1,572 |
| 2012-06-30 | $1,551 |
| 2012-03-31 | $1,525 |
| 2011-12-31 | $1,511 |
| 2011-09-30 | $1,703 |
| 2011-06-30 | $1,676 |
| 2011-03-31 | $1,655 |
| 2010-12-31 | $1,535 |
| 2010-09-30 | $1,359 |
| 2010-06-30 | $1,354 |
| 2010-03-31 | $1,305 |
| 2009-12-31 | $1,289 |
| 2009-09-30 | $1,257 |
| 2009-06-30 | $1,251 |
| 2009-03-31 | $1,238 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.859B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $88.397B | 10.97 |
| Cencora (COR) | United States | $45.651B | 17.16 |
| Natera (NTRA) | United States | $23.104B | 0.00 |
| DiDi Global (DIDIY) | China | $21.969B | 0.00 |
| ICON (ICLR) | Ireland | $18.002B | 16.03 |
| Avantor (AVTR) | United States | $14.742B | 22.10 |
| Viatris (VTRS) | United States | $13.929B | 4.29 |
| BioMerieux (BMXMF) | France | $12.558B | 0.00 |
| CochLear (CHEOY) | Australia | $12.074B | 0.00 |
| Solventum (SOLV) | United States | $11.587B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.906B | 30.72 |
| Doximity (DOCS) | United States | $9.727B | 57.25 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.707B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.517B | 18.39 |
| HealthEquity (HQY) | United States | $8.694B | 43.62 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.259B | 29.11 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $4.082B | 4.12 |
| Sotera Health (SHC) | United States | $3.713B | 19.86 |
| BrightSpring Health Services (BTSG) | United States | $2.990B | 63.59 |
| Surgery Partners (SGRY) | United States | $2.625B | 29.93 |
| Concentras Parent (CON) | United States | $2.513B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.455B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.277B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.006B | 10.44 |
| PACS (PACS) | United States | $1.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.734B | 45.50 |
| Teladoc Health (TDOC) | United States | $1.699B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Progyny (PGNY) | United States | $1.597B | 32.34 |
| Establishment Labs Holdings (ESTA) | $1.282B | 0.00 | |
| CareDx (CDNA) | United States | $1.267B | 0.00 |
| Embecta (EMBC) | United States | $1.132B | 7.92 |
| Pediatrix Medical (MD) | United States | $1.068B | 10.45 |
| AMN Healthcare Services Inc (AMN) | United States | $1.023B | 6.93 |
| Agilon Health (AGL) | United States | $1.001B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.563B | 14.73 |
| SBC Medicals (SBC) | United States | $0.526B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.490B | 0.00 |
| DocGo (DCGO) | United States | $0.416B | 15.69 |
| Sonida Senior Living (SNDA) | United States | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.242B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.234B | 0.00 |
| MultiPlan (MPLN) | United States | $0.206B | 0.00 |
| LifeMD (LFMD) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.197B | 0.00 |
| Beauty Health (SKIN) | United States | $0.192B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.168B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.70 |
| ModivCare (MODV) | United States | $0.094B | 5.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |